Candel Therapeutics, Inc. ( CADL) - Key Metrics

CADL Revenue per Share metrics

Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q3 $0 -$0.28 -$0.30 -$0.30
2026Q2 $0 -$0.52 -$0.23 -$0.23
2026Q1 $0 -$0.14 -$0.29 -$0.30
2025Q4 $0 -$0.54 -$0.19 -$0.20
2025Q3 $0 -$0.21 -$0.19 -$0.19

CADL Payout ratio and Price per Earnings ratio

Date Payout ratio PE ratio
2026Q3 0% -9.32
2026Q2 0% -4.95
2026Q1 0% -8.75
2025Q4 0% -2.62
2025Q3 0% -6.07

CADL

Price: $4.96

52 week price:
4.35
14.00

Earnings Per Share: -1.53 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 14500

Market Capitalization: 423.6 million

Links: